Paper41254656
Nanodynamic therapy for cancer: mechanistic innovations, targeting strategies and multimodal treatments.
Li Y and 12 others. J Transl Med, 2025. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Nanodynamic therapy for cancer: mechanistic innovations, targeting strategies and multimodal treatments. Papers, record 41254656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41254656
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Nanodynamic therapy for cancer: mechanistic innovations, targeting strategies and multimodal treatments.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Nanomedicine | Major topic |
| Humans | |
| Combined Modality Therapy | |
| Animals | |
| Photochemotherapy | |
| Drug Delivery Systems |
Source PubMed
References359
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33565157 | Emerging Nanomedicine-Enabled/Enhanced Nanodynamic Therapies beyond Traditional Photodynamics. | Adv Mater | 2021 | https://conductscience.org/library/papers/33565157 | PubMed |
| 2 | 39613128 | One stone, three birds: Construction of Cu/ZIF-8@DSF@GOx/HA nanoplatform for synergistic starvation therapy enhanced chemo-/chemodynamic therapy. | Nanomedicine | 2025 | https://conductscience.org/library/papers/39613128 | PubMed |
| 3 | 37340824 | Lysosome- and plasma membrane-accumulative and tumor-targetable polythiophene nanoparticles for enhanced sonodynamic therapy. | J Mater Chem B | 2023 | https://conductscience.org/library/papers/37340824 | PubMed |
| 4 | 30836772 | A novel conjunction of folate-targeted carbon nanotubes containing protohemin and oridonin-liposome loaded microbubbles for cancer chemo-sonodynamic therapy. | J Drug Target | 2019 | https://conductscience.org/library/papers/30836772 | PubMed |
| 5 | 32737907 | Natural Polyphenol-Vanadium Oxide Nanozymes for Synergistic Chemodynamic/Photothermal Therapy. | Chemistry | 2020 | https://conductscience.org/library/papers/32737907 | PubMed |
| 6 | 25990106 | Temoporfin improves efficacy of photodynamic therapy in advanced biliary tract carcinoma: A multicenter prospective phase II study. | Hepatology | 2015 | https://conductscience.org/library/papers/25990106 | PubMed |
| 7 | 36859811 | Drug Discovery Perspectives of Antisense Oligonucleotides. | Biomol Ther (Seoul) | 2023 | https://conductscience.org/library/papers/36859811 | PubMed |
| 8 | 32165281 | Lipid peroxidation and ferroptosis: The role of GSH and GPx4. | Free Radic Biol Med | 2020 | https://conductscience.org/library/papers/32165281 | PubMed |
| 9 | 32337527 | Multifunctional sonosensitizers in sonodynamic cancer therapy. | Chem Soc Rev | 2020 | https://conductscience.org/library/papers/32337527 | PubMed |
| 10 | 38738822 | Highly Effective Pyroelectric Catalysis for Simultaneous Tumor-Targeted Dynamic Therapy and Gentle Photothermal Therapy by Oxygen-Vacancy-Rich CeO2-BaTiO3 Nanorods. | Adv Healthc Mater | 2024 | https://conductscience.org/library/papers/38738822 | PubMed |
| 11 | 32036302 | Advances in nanomaterials for photodynamic therapy applications: Status and challenges. | Biomaterials | 2020 | https://conductscience.org/library/papers/32036302 | PubMed |
| 12 | 36690036 | A positive self-amplified H2O2 and acidity circulation for boosting CDT-PTT-starvation therapy. | J Control Release | 2023 | https://conductscience.org/library/papers/36690036 | PubMed |
| 13 | 37240331 | Calcium's Role in Orchestrating Cancer Apoptosis: Mitochondrial-Centric Perspective. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37240331 | PubMed |
| 14 | 35524448 | Endoplasmic reticulum stress in liver diseases. | Hepatology | 2023 | https://conductscience.org/library/papers/35524448 | PubMed |
| 15 | 31233920 | Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy. | Eur J Med Chem | 2019 | https://conductscience.org/library/papers/31233920 | PubMed |
| 16 | 33277608 | Engineering precision nanoparticles for drug delivery. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33277608 | PubMed |
| 17 | 30023938 | Targeting of a Photosensitizer to the Mitochondrion Enhances the Potency of Photodynamic Therapy. | ACS Omega | 2018 | https://conductscience.org/library/papers/30023938 | PubMed |
| 18 | 34204001 | Radiodynamic Therapy Using TAT Peptide-Targeted Verteporfin-Encapsulated PLGA Nanoparticles. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34204001 | PubMed |
| 19 | 38542401 | Tumor-Targeted Squaraine Dye for Near-Infrared Fluorescence-Guided Photodynamic Therapy. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38542401 | PubMed |
| 20 | 35361964 | Cell cycle regulation: p53-p21-RB signaling. | Cell Death Differ | 2022 | https://conductscience.org/library/papers/35361964 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42910162 | Harnessing ultrasound-responsive technologies for precision periodontitis therapy: a perspective. | Theranostics | 2026 | https://conductscience.org/library/papers/42910162 | PubMed |
| 42896974 | [Mechanisms and Clinical Translation Advances of Physical Targeted Therapy for Malignant Pleural Effusion]. | Zhongguo Fei Ai Za Zhi | 2026 | https://conductscience.org/library/papers/42896974 | PubMed |
| 42796510 | Reprogramming Photodynamic Therapy with BODIPY Photosensitizers: From Local Phototoxicity Toward Precision Photodynamic Oncology. | Molecules | 2026 | https://conductscience.org/library/papers/42796510 | PubMed |
| 42761669 | Precision Multimodal Nanodynamic Therapy for Lung Cancer: From Tumor Microenvironment-Responsive Platforms to Cell-Death Reprogramming and Immune Remodeling. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42761669 | PubMed |
| 42713166 | Amphiphilic Aminated [60] Fullerene Potentiates Radiofrequency Ablation for Synergistic Cancer Treatment. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42713166 | PubMed |
| 42610073 | Nanotechnology in Prostate Cancer: PSMA-Targeted Nanoplatforms, TME-Responsive Therapy, Immunomodulation, and Clinical Translation Challenges. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42610073 | PubMed |
| 42609883 | Polymeric Nanoparticles for Precision Tumor Immunotherapy: Rational Design Strategies and Spatiotemporal Immune Activation. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42609883 | PubMed |
| 42452077 | Thermoresponsive Injectable Self-Healing Hydrogel Loaded with Self-Regenerating Photothermal Agent for Synergistic Photothermal-Thermodynamic-Chemodynamic Therapy for Pancreatic Cancer. | Polymers (Basel) | 2026 | https://conductscience.org/library/papers/42452077 | PubMed |
| 41947122 | Nanomedicine in immunotherapy of urinary system tumors: advances, synergistic strategies, and translational challenges. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41947122 | PubMed |
| 41907375 | Nanodynamic Therapy in Colorectal Cancer: Engineering Precision Immunotherapy and Multimodal Synergy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41907375 | PubMed |
| 41884284 | Tumor Microenvironment-Responsive Nanomedicine: Monitoring and Modulating the Tumor Microenvironment for Precision Cancer Therapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41884284 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41254656
GET https://conductscience.org/api/papers/v1/41254656/references?page=2